Basel Medical Group Ltd (BMGL)

Market Cap	83.60M
Revenue (ttm)	7.43M
Net Income (ttm)	1.53M
Shares Out	18.79M
EPS (ttm)	0.09
PE Ratio	47.29
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	78,689
Open	4.400
Previous Close	4.410
Day's Range	4.400 - 4.480
52-Week Range	3.630 - 5.500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BMGL

Basel Medical Group Ltd engages in the provision of healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures. Its services also include consultation, medical diagnosis, and medical and surgical treatments for orthopedic, trauma, sports medicine, and neurological conditions. The company was incorporated in 2023 and is based i...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Feb 25, 2025
• Employees: 32
• Stock Exchange: NASDAQ
• Ticker Symbol: BMGL
• Website: https://baselmedical.com

Financial Performance

In 2024, Basel Medical Group's revenue was 10.07 million, an increase of 3.32% compared to the previous year's 9.75 million. Earnings were 2.07 million, an increase of 16.23%.

Financial numbers in SGD